Featured Research

from universities, journals, and other organizations

Common Treatment For Diabetic Crisis In Children May Contribute To Rare But Often Fatal Complication

Date:
January 26, 2001
Source:
University Of California, Davis, Medical Center
Summary:
A common treatment for children in diabetic crisis should be abandoned in most cases because it appears to contribute to a rare but often-fatal complication known as cerebral edema, according to a study by researchers at UC Davis School of Medicine and Medical Center. The study also identifies two simple blood test measurements that can help doctors predict which patients are in greatest danger of developing the potentially deadly complication.

(Sacramento, Calif.) - A common treatment for children in diabetic crisis should be abandoned in most cases because it appears to contribute to a rare but often-fatal complication known as cerebral edema, according to a study by researchers at UC Davis School of Medicine and Medical Center. The study also identifies two simple blood test measurements that can help doctors predict which patients are in greatest danger of developing the potentially deadly complication.

The study, the largest and most statistically rigorous examination yet of risk factors for cerebral edema in children with diabetic ketoacidosis, appears in the Jan. 25 issue of the New England Journal of Medicine.

The researchers found that bicarbonate, a common treatment for diabetic ketoacidosis, appears to increase the risk of cerebral edema, or swelling of the brain, which can be fatal. In ketoacidosis, toxic levels of acids called ketones build up in the blood. Bicarbonate is often given in the emergency department to reduce these acid levels.

"In the past there has been some suspicion that giving bicarbonate can increase risk of cerebral edema, but ours is the first study to show that it can," said Nathan Kuppermann, senior author of the study, a pediatric emergency physician and associate professor of internal medicine at UC Davis. "I imagine doctors in emergency departments and pediatric intensive care units will put this knowledge into effect immediately."

The UC Davis researchers, led by Nicole Glaser, a pediatric endocrinologist and assistant professor of pediatrics, also found that children with diabetic ketoacidosis who have lower initial arterial carbon dioxide measurements and higher serum urea nitrogen concentrations are at increased risk for cerebral edema. When a child shows up at an emergency department with diabetic ketoacidosis, blood tests for carbon dioxide and urea nitrogen levels are routinely ordered.

"Until now, no one really knew who was at greatest risk for developing cerebral edema. We determined which of the tests that doctors routinely order are most predictive of who will go on to develop cerebral edema," Glaser said. "The hope is that by knowing these risk factors, doctors will be able to better monitor the high-risk children, and pick up the initial signs of this complication before it progresses to a more serious stage."

Cerebral edema can lead to coma, neurological damage, and death. While the complication occurs in only about 1 percent of diabetic ketoacidosis cases in children, 40 percent to 90 percent of the children who develop cerebral edema die, and many others are left with permanent brain damage. In all, cerebral edema accounts for 50 percent to 60 percent of diabetes-related deaths in children.

"Children with low carbon dioxide and high urea nitrogen should be monitored extensively for signs of neurologic deterioration, and hyperosmolar therapy (to reduce swelling) should be immediately available if early signs of cerebral edema occur," Glaser and her co-authors recommend in their article.

In addition, the authors state that "treatment with bicarbonate is associated with increased risk of cerebral edema and should be avoided in most circumstances."

Caused by too little insulin in the body, diabetic ketoacidosis occurs mainly in patients with type I diabetes mellitus, also known as juvenile diabetes or insulin- dependent diabetes. Symptoms of ketoacidosis include unusual thirst, frequent urination, constant fatigue, dry or flushed skin, nausea and vomiting, labored breathing, confusion, and a fruity odor on the breath. The condition requires immediate emergency medical intervention.

For 25 percent to 40 percent of children with new-onset type I diabetes, ketoacidosis is the first recognized sign of disease. Ketoacidosis also can occur later in the course of the disease if a diabetic patient misses an insulin injection, gets sick or is subjected to some other significant stress.

Kristi Oppold, of Woodland, Calif., is among the 25 percent to 40 percent of children who first found out she had diabetes when she developed ketoacidosis. She is also one of the rare children to develop cerebral edema. Fortunately, she survived without any permanent neurological damage.

"It is the scariest thing IÕve ever experienced," Terri Oppold says of her daughter's 12-hour coma, brought on by the brain swelling. "No child should have to go through this."

In their study, Glaser and her colleagues reviewed the medical charts of 6,977 children hospitalized for diabetic ketoacidosis over a 15-year period at 10 medical centers. These children were compared with two control groups of children with diabetic ketoacidosis who did not develop cerebral edema. Comparisons among the groups were subjected to a series of sophisticated statistical tests.

Other studies have attempted to identify risk factors for cerebral edema in children with diabetic ketoacidosis. However, the studies were small, lacked control groups for comparison, and reached contradictory findings.

Each year 30,000 Americans are diagnosed with type I diabetes, more than 13,000 of them children, according to the Juvenile Diabetes Foundation. In type I diabetes, the pancreas produces little or no insulin. Because insulin is necessary for life, sufferers must take multiple insulin injections a day for the rest of their lives.

This study was supported by grants from the Children's Miracle Network and the Ambulatory Pediatrics Association.


Story Source:

The above story is based on materials provided by University Of California, Davis, Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

University Of California, Davis, Medical Center. "Common Treatment For Diabetic Crisis In Children May Contribute To Rare But Often Fatal Complication." ScienceDaily. ScienceDaily, 26 January 2001. <www.sciencedaily.com/releases/2001/01/010125082645.htm>.
University Of California, Davis, Medical Center. (2001, January 26). Common Treatment For Diabetic Crisis In Children May Contribute To Rare But Often Fatal Complication. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2001/01/010125082645.htm
University Of California, Davis, Medical Center. "Common Treatment For Diabetic Crisis In Children May Contribute To Rare But Often Fatal Complication." ScienceDaily. www.sciencedaily.com/releases/2001/01/010125082645.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) — Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) — The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) — Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) — New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins